Sexual dysfunction caused by psychiatric medications like SSRIs and lithium can be permanent.
Evidence from recent clinical reviews and studies supports the existence of post-SSRI sexual dysfunction (PSSD), confirming that sexual dysfunction caused by psychiatric medications like SSRIs can persist long after discontinuation.
The retrieved literature consistently discusses Post-SSRI Sexual Dysfunction (PSSD) as a recognized, persistent condition where sexual adverse effects continue for months or years after medication cessation. The claim is specific, testable, and supported by multiple reviews and clinical studies in the provided set.
A Goldstein, N Kim, S Goldstein, A Drian, A Bajwa, I Goldstein. (313) Sexual Symptoms and Biologic Pathophysiologies of Post-SSRI Sexual Dysfunction: A 15 Year Review. 2025. https://doi.org/10.1093/jsxmed/qdaf320.309
Identifies post-SSRI sexual dysfunction (PSSD) as a condition where sexual side effects persist for six months or more after discontinuation.
See more details
Xie M, Huang P, Wang S, Ma J, Zeng Y, Sun J. Post-SSRI Sexual Dysfunction (PSSD): A comprehensive review of epidemiology, pathophysiology, and clinical management.. 2026. https://doi.org/10.1177/09246479261468499
Describes PSSD as a persistent iatrogenic syndrome of sexual dysfunction and genital anesthesia continuing after drug cessation.
Linke J, Majcherek E, Leszyńska A, Wawrzyniak M, Gałczyńska-Rusin M, Niemczyńska A, Ferensztajn-Rochowiak E. Characteristics and risk factors of Post SSRI Sexual Dysfunction (PSSD). 2025. https://doi.org/10.21203/rs.3.rs-7750807/v1
Notes that sexual satisfaction significantly decreased post-treatment in individuals experiencing persistent symptoms after discontinuing antidepressants.
Gertsman S, Ashley M, Akenson G, Pukall C. Persistent Sexual Side Effects After Discontinuation of SRIs: Protocol for a Scoping Review of Symptoms and Birth-Assigned Sex Comparisons. 2025. https://doi.org/10.31234/osf.io/6w2u9_v1
Acknowledges that while sexual side effects usually resolve, they can persist chronically after treatment cessation as PSSD.
Shaw J, Lai C, Bota P, Le A, Andricioaei A, Tran T, Allee T. The Off-Label Use of Selective Serotonin Reuptake Inhibitors for Sexual Behavior Management: Risks and Considerations.. 2025. https://doi.org/10.3390/healthcare13192433
Highlights that the risk of enduring PSSD poses a significant concern for patients taking serotonin reuptake inhibitors.
The paper trail · every fact has a biography
Challenge the receipt
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
Terms · Privacy · How verdicts work · Dispute this receipt